EllieMD Dihexa Dihexa c Met HGFR TargetMol After being placed into FDA Category 2 in 2023, several widely discussed peptides faced restricted pathways for regulated compounding. This shift pushed demand toward unregulated markets and created significant uncertainty across the Dihexa (10mg) x 30 Tablets Paramount Peptides Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest What's happening with peptides right now is a major shift in how this space will be practiced. After a period of broad restriction, we're moving back toward substance specific evaluation and back into